MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-30-0009887
Synnova Intermediates Private Limited
Synnova Intermediates Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.29 Cr
▲ 18325% YoY
Net loss · FY 2025
₹42.2 Lakh
Net margin -8%
EBITDA · FY 2025
₹29.32 Lakh
EBITDA margin 5.5%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹8.81 Cr
Issued & subscribed
Open charges
₹4 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Synnova Intermediates Private Limited
Data last updated:
Synnova Intermediates Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2020PTC344337. Its GSTIN is 27ABECS2518R1ZS (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹8.81 Cr. It is led by directors including Ruchir Vishwaprakash Mundra and Anuj Arun Verma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 104 Terminal – 9 Nehru Road Nr. Vile Parle Police Station Vile Parle East, Mumbai, Maharashtra, India – 400057.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.29 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹42.2 Lakh (net margin -8%) and EBITDA of ₹29.32 Lakh (EBITDA margin 5.5%).
As per MCA filings, the company has open charges of ₹4 Cr on record.
Synnova Intermediates Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-30-0009887). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Synnova Intermediates Private Limited
CIN U24100MH2020PTC344337
Registration Number 344337
Incorporation Date 23 August 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-30-0009887
Recognitions & Rankings of Synnova Intermediates
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address104 Terminal – 9 Nehru Road Nr. Vile Parle Police Station Vile Parle East, Mumbai, Maharashtra, India – 400057
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Synnova Intermediates Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Synnova Intermediates Private Limited
The main business activity of Synnova Intermediates is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Synnova Intermediates Private Limited FY 2024 filings available
Synnova Intermediates Private Limited reported revenue of ₹5.29 Cr (up 18325% YoY) for FY 2025.
Revenue · FY 2025
₹5.29 Cr ▲ 18325%
Net loss · FY 2025
₹42.2 Lakh margin -8%
EBITDA · FY 2025
₹29.32 Lakh margin 5.5%
Financial Statement Summary of Synnova Intermediates Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹29.32 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹42.2 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Synnova Intermediates Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Synnova Intermediates are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Synnova Intermediates Private Limited
Synnova Intermediates has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ruchir Vishwaprakash Mundra Also directs: Rugvija Brands LLP, Basic Engineering Private Limited, Siddha Vanijya Private Limited and 1 more | Director | 23 Aug 2020 | 6 Years 1 Months | Current |
| Anuj Arun Verma | Director | 23 Aug 2020 | 6 Years 1 Months | Current |
| Ankur Goel | Director | 23 Aug 2020 | 6 Years 1 Months | Current |
Peer Comparison of Synnova Intermediates Private Limited
Synnova Intermediates Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lexus India Limited | ₹5.32 Cr (FY 2024) | •••• | •••• | 99.0% | •••• | New Delhi, Delhi, India |
| Meticulous Pharmaceticals Private Limited | ₹5.31 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Uttar Pradesh, India |
| Swastik Formulations Private Limited | ₹5.3 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Uttar Pradesh, India |
| Nupur Pharma Private Limited | ₹5.3 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Delhi, India |
| Edence Life Sciences Private Limited | ₹5.29 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Synnova Intermediates Private Limited this company | ₹5.29 Cr (FY 2025) | •••• | •••• | 18325.0% | •••• | Mumbai, Maharashtra, India |
| Axolab Formulations Private Limited | ₹5.29 Cr (FY 2025) | •••• | •••• | 824.0% | •••• | Solan, Himachal Pradesh, India |
| SPR Oncocare Private Limited | ₹5.28 Cr (FY 2025) | •••• | •••• | 80.0% | •••• | Bangalore, Karnataka, India |
| Sure for Cure Farmulations (India ) Private Limited | ₹5.27 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Uttar Pradesh, India |
| Taj Pharma India Limited | ₹5.27 Cr (FY 2025) | •••• | •••• | 1274.0% | •••• | Mumbai, Maharashtra, India |
| Santo Medi Sciences Private Limited | ₹5.27 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Varanasi, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Synnova Intermediates by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Synnova Intermediates Private Limited
Synnova Intermediates Private Limited is audited by JAIN NIRMAL & CO. for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAIN NIRMAL & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Synnova Intermediates Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Synnova Intermediates Private Limited
Open charges
₹4 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2023 | Hdfc Bank Limited | ₹4 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Synnova Intermediates Private Limited
Synnova Intermediates Private Limited has a workforce of 0 employees as of Apr 06, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Synnova Intermediates Private Limited
Synnova Intermediates Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Ankur Goel was appointed as Director on 23 Aug 2020.
AGM
Synnova Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Synnova Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited of Rs. 4.00 Cr registered on 29 Nov 2023 with Charge ID 100865992 was modified on 08 Jan 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.00 Cr with Charge ID 100865992 was registered on 29 Nov 2023.
Appointed
Ankur Goel was appointed as Director.
Appointed
Anuj Arun Verma was appointed as Director.
Appointed
Ruchir Vishwaprakash Mundra was appointed as Director.
Incorporation
23 Aug 2020
Synnova Intermediates Private Limited was registered on 23 Aug 2020 with Roc Mumbai & aged 6 years 1 month as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Synnova Intermediates Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Synnova Intermediates Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Synnova Intermediates Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Synnova Intermediates Private Limited
Synnova Intermediates has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABECS2518R1ZS | Maharashtra | Active | 26 Aug 2020 |
| 29ABECS2518R1ZO | Karnataka | Active | 26 Nov 2022 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Synnova Intermediates Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synnova Intermediates Private Limited
Synnova Intermediates is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 August 2020 (6+ years old) and is registered under CIN U24100MH2020PTC344337.
Synnova Intermediates reported revenue of ₹5.29 Cr for FY 2025 (up 18325% YoY).
Synnova Intermediates has 3 current directors:
- Ruchir Vishwaprakash Mundra - Director
- Anuj Arun Verma - Director
- Ankur Goel - Director
Synnova Intermediates reported a net loss of ₹42.2 Lakh (net margin -8%) and EBITDA of ₹29.32 Lakh (EBITDA margin 5.5%) for FY 2025, as per its filed financial statements.
The GSTIN of Synnova Intermediates is 27ABECS2518R1ZS, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29ABECS2518R1ZO (Karnataka).
The CIN (Corporate Identification Number) of Synnova Intermediates is U24100MH2020PTC344337. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synnova Intermediates was incorporated on 23 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Synnova Intermediates by revenue are Lexus India Limited, Meticulous Pharmaceticals Private Limited, Swastik Formulations Private Limited, Nupur Pharma Private Limited, Edence Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Ankur Goel was appointed as Director on 23 Aug 2020. Anuj Arun Verma was appointed as Director on 23 Aug 2020. Ruchir Vishwaprakash Mundra was appointed as Director on 23 Aug 2020.
Yes, Synnova Intermediates is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-30-0009887).
The registered office of Synnova Intermediates is at 104 Terminal – 9 Nehru Road Nr. Vile Parle Police Station Vile Parle East, Mumbai, Maharashtra, India – 400057.